GRUPO ESPAÑOL DE ONCOLOGÍA OCULAR
ENSAYOS E INVESTIGACIONES
ARTÍCULOS PUBLICADOS POR EL GEOO
1. Bande MF, Santiago M, Muinelo‐Romay L, Blanco MJ, Mera P, Capeans C, Pardo M, Piñeiro A. Detection of circulating melanoma cells in choroidal melanocytic lesions. BMC Res Notes. 2015; 7; 8:452.
2. Varela-Calviño R, Imbernón M, Vázquez-Iglesias L, Páez de la Cadena M, Bande-Rodríguez M, Piñeiro A, Pardo M, Cordero OJ. Serum dipeptidyl peptidase IV activity and sCD26 concentration in patients with choroidal nevus or uveal melanoma. Clin Chim Acta. 2015; 25; 448:193‐4
3. Bande MF, Santiago M, Mera P, Piulats JM, Blanco MJ, Rodríguez‐Álvarez MX, Capeans C, Piñeiro A, Pardo M.ME20‐S as a Potential Biomarker for the Evaluation of Uveal Melanoma. Invest Ophthalmol Vis Sci. 2015; 56:7007‐11
4. Piñeiro‐Ces A, Rodríguez Alvarez MJ, Santiago M, Bande M, Pardo M, Capeáns C, Blanco MJ. Detecting ultrasonographic hollowness in small choroidal melanocytic tumors using 10 MHz and 20 MHz ultrasonography: a comparative study. Graefes Arch Clin Exp Ophthalmol. 2014; 252:2005‐11.
5. Bande MF, Santiago M, Blanco MJ, Mera P, Capeans C, Rodríguez‐Alvarez MX, Pardo M, Piñeiro A. Serum DJ‐1/PARK 7 is a potential biomarker of choroidal nevi transformation. Invest Ophthalmol Vis Sci 2012; 53:62‐7.
ESTUDIOS CLÍNICOS EN CURSO SOBRE MELANOMA UVEAL
1. Vorinostat in Treating Patients with Metastatic Melanoma of the Eye
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AAAO5917, NCI-2012-00860, CUMC-IRBAAAO5917, MSKCC-12-027, 9111, 12-027, NCT01587352
2. Glembatumumab Vedotin in Treating Patients with Metastatic or Locally Recurrent Uveal Melanoma
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9855, NCI-2015-00159, NCI9855, NCT02363283
3. Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 99
Trial IDs: IMCgp100-202, NCI-2017-00590, NCT03070392
4. Sotrastaurin Acetate and Alpelisib in Treating Patients with Metastatic Uveal Melanoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AAAN4901, NCI-2015-00753, CAEB071AUS01T, NCT02273219